Anti-AAV9 VP1/Capsid protein VP1 Antibody (SAA2503)
The Anti-AAV9 VP1/Capsid protein VP1 Antibody (SAA2503) is a highly specific and potent antibody designed for the detection and analysis of AAV9 VP1/Capsid protein in various biological samples. This antibody is produced using advanced biotechnology techniques and has been extensively tested to ensure its high specificity and sensitivity.
Biological Function
The AAV9 VP1/Capsid protein is a key component of adeno-associated virus 9 (AAV9), a viral vector commonly used in gene therapy and gene delivery applications. The AAV9 VP1/Capsid protein is responsible for binding to host cells and facilitating the transfer of genetic material, making it a crucial target for research and development in the biotech industry.
Main Applications
The Anti-AAV9 VP1/Capsid protein VP1 Antibody (SAA2503) is an essential tool for researchers studying AAV9 and its role in gene therapy. This antibody can be used in various applications, including Western blotting, immunohistochemistry, and immunofluorescence, to detect and quantify AAV9 VP1/Capsid protein in biological samples. It is also suitable for use in flow cytometry and ELISA assays.
Experimental Use Cases
The Anti-AAV9 VP1/Capsid protein VP1 Antibody (SAA2503) has been extensively used in various research studies to investigate the function and expression of AAV9 VP1/Capsid protein. It has been shown to effectively detect AAV9 VP1/Capsid protein in transduced cells and tissues, making it a valuable tool for gene therapy research. Additionally, this antibody has been used in preclinical studies to evaluate the efficacy and safety of AAV9-based gene therapies.
With its high specificity and sensitivity, the Anti-AAV9 VP1/Capsid protein VP1 Antibody (SAA2503) is a reliable and essential tool for researchers in the biotech industry. It is a valuable addition to any laboratory studying AAV9 and its potential applications in gene therapy. Order now and take your research to the next level.
There are no reviews yet.